{"transactions":[{"id":4619914,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-16T21:52:03.000Z","date":"2026-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5396,"price":3.41,"value":18400.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1071462,"source":{"system":"sec-edgar","filing":"0001601830-26-000110","document":"wk-form4_1789595520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712276/000160183026000110/wk-form4_1789595520.xml","form_type":"4"}},{"id":682793,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-18T21:44:23.000Z","date":"2026-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":25018,"price":3.16,"value":79056.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1076858,"source":{"system":"sec-edgar","filing":"0001712276-26-000009","document":"wk-form4_1787089461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000009/wk-form4_1787089461.xml","form_type":"4"}},{"id":733408,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-17T21:07:31.000Z","date":"2026-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5396,"price":3.15,"value":16997.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1101876,"source":{"system":"sec-edgar","filing":"0001712276-26-000007","document":"wk-form4_1781730449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000007/wk-form4_1781730449.xml","form_type":"4"}},{"id":771241,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:44.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":25018,"price":3.04,"value":76054.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1107272,"source":{"system":"sec-edgar","filing":"0001712276-26-000005","document":"wk-form4_1779227682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000005/wk-form4_1779227682.xml","form_type":"4"}},{"id":812293,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:58:31.000Z","date":"2026-04-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":48028,"price":3.11,"value":149367.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1132290,"source":{"system":"sec-edgar","filing":"0001712276-26-000003","document":"wk-form4_1775681908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000003/wk-form4_1775681908.xml","form_type":"4"}},{"id":834504,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-18T21:52:36.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":7956,"price":3.39,"value":26970.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."}],"balance_after":1180318,"source":{"system":"sec-edgar","filing":"0001712276-26-000002","document":"wk-form4_1773870740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000002/wk-form4_1773870740.xml","form_type":"4"}},{"id":834503,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-18T21:52:36.000Z","date":"2026-03-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":7075,"price":3.42,"value":24196.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1188274,"source":{"system":"sec-edgar","filing":"0001712276-26-000002","document":"wk-form4_1773870740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000002/wk-form4_1773870740.xml","form_type":"4"}},{"id":892625,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:45.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":13426,"price":3.08,"value":41352.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."}],"balance_after":1195349,"source":{"system":"sec-edgar","filing":"0001601830-26-000020","document":"wk-form4_1771547442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000020/wk-form4_1771547442.xml","form_type":"4"}},{"id":892624,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:45.000Z","date":"2026-02-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":11908,"price":3.49,"value":41558.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1208775,"source":{"system":"sec-edgar","filing":"0001601830-26-000020","document":"wk-form4_1771547442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000020/wk-form4_1771547442.xml","form_type":"4"}},{"id":911384,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:20.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":11400,"price":3.98,"value":45372.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1220683,"source":{"system":"sec-edgar","filing":"0001601830-26-000013","document":"wk-form4_1770765498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000013/wk-form4_1770765498.xml","form_type":"4"}},{"id":911383,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:20.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":24254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":1232083,"source":{"system":"sec-edgar","filing":"0001601830-26-000013","document":"wk-form4_1770765498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000013/wk-form4_1770765498.xml","form_type":"4"}},{"id":911382,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:20.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":446279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter."}],"balance_after":1207829,"source":{"system":"sec-edgar","filing":"0001601830-26-000013","document":"wk-form4_1770765498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000013/wk-form4_1770765498.xml","form_type":"4"}},{"id":956994,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-31T00:35:12.000Z","date":"2025-12-29","kind":"sale","planned":true,"acquired":false,"shares":21383,"price":4.18,"value":89380.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."}],"balance_after":761550,"source":{"system":"sec-edgar","filing":"0001712276-25-000017","document":"wk-form4_1767141308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227625000017/wk-form4_1767141308.xml","form_type":"4"}},{"id":964369,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-17T23:34:04.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7057,"price":4.33,"value":30556.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":782933,"source":{"system":"sec-edgar","filing":"0001712276-25-000015","document":"wk-form4_1766014441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227625000015/wk-form4_1766014441.xml","form_type":"4"}},{"id":986590,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-26T22:14:28.000Z","date":"2025-11-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2271,"price":4.03,"value":9152.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":789990,"source":{"system":"sec-edgar","filing":"0001712276-25-000013","document":"wk-form4_1764195265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227625000013/wk-form4_1764195265.xml","form_type":"4"}},{"id":993462,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-20T00:37:39.000Z","date":"2025-11-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":11908,"price":4.14,"value":49299.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":792261,"source":{"system":"sec-edgar","filing":"0001712276-25-000011","document":"wk-form4_1763599056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227625000011/wk-form4_1763599056.xml","form_type":"4"}},{"id":1037263,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-17T20:45:37.000Z","date":"2025-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7057,"price":4.83,"value":34085.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":804169,"source":{"system":"sec-edgar","filing":"0001601830-25-000147","document":"wk-form4_1758141935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000147/wk-form4_1758141935.xml","form_type":"4"}},{"id":1061224,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-19T22:22:14.000Z","date":"2025-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11908,"price":5.64,"value":67161.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":811226,"source":{"system":"sec-edgar","filing":"0001601830-25-000133","document":"wk-form4_1755642130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000133/wk-form4_1755642130.xml","form_type":"4"}},{"id":1105955,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:32:45.000Z","date":"2025-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7057,"price":4.92,"value":34720.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":823134,"source":{"system":"sec-edgar","filing":"0001601830-25-000091","document":"wk-form4_1750278755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000091/wk-form4_1750278755.xml","form_type":"4"}},{"id":1141915,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-19T20:44:12.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11908,"price":4.25,"value":50609.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":830191,"source":{"system":"sec-edgar","filing":"0001601830-25-000083","document":"wk-form4_1747687446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000083/wk-form4_1747687446.xml","form_type":"4"}},{"id":1178788,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-03T20:38:14.000Z","date":"2025-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":26571,"price":5.095,"value":135379.245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":842099,"source":{"system":"sec-edgar","filing":"0001601830-25-000057","document":"wk-form4_1743712677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000057/wk-form4_1743712677.xml","form_type":"4"}},{"id":1196779,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-19T20:27:38.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":7057,"price":6.84,"value":48269.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":868670,"source":{"system":"sec-edgar","filing":"0001601830-25-000049","document":"wk-form4_1742416051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000049/wk-form4_1742416051.xml","form_type":"4"}},{"id":1255012,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-20T21:42:42.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":10879,"price":10.64,"value":115752.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":875727,"source":{"system":"sec-edgar","filing":"0001601830-25-000019","document":"wk-form4_1740087755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000019/wk-form4_1740087755.xml","form_type":"4"}},{"id":1281442,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-05T21:50:41.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":70037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter."}],"balance_after":70037,"derivative":{"exercise_price":7.25,"expiration_date":"2035-02-03","underlying":"Class A Common Stock","underlying_shares":70037},"source":{"system":"sec-edgar","filing":"0001628280-25-004088","document":"wk-form4_1738792233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000162828025004088/wk-form4_1738792233.xml","form_type":"4"}},{"id":1281441,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-05T21:50:41.000Z","date":"2025-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6544,"price":7.25,"value":47444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":886606,"source":{"system":"sec-edgar","filing":"0001628280-25-004088","document":"wk-form4_1738792233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000162828025004088/wk-form4_1738792233.xml","form_type":"4"}},{"id":1281440,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-05T21:50:41.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":13922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":893150,"source":{"system":"sec-edgar","filing":"0001628280-25-004088","document":"wk-form4_1738792233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000162828025004088/wk-form4_1738792233.xml","form_type":"4"}},{"id":1281439,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-05T21:50:41.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":35018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2025 and every three months thereafter."}],"balance_after":879228,"source":{"system":"sec-edgar","filing":"0001628280-25-004088","document":"wk-form4_1738792233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000162828025004088/wk-form4_1738792233.xml","form_type":"4"}},{"id":1323871,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-20T21:16:57.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":740686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the award vests and become exercisable on January 2, 2025, and each month thereafter, subject to Mr. Taylor's continued service through each vesting date."}],"balance_after":740686,"derivative":{"exercise_price":6.09,"expiration_date":"2034-12-18","underlying":"Class A Common Stock","underlying_shares":740686},"source":{"system":"sec-edgar","filing":"0001601830-24-000249","document":"wk-form4_1734729410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000249/wk-form4_1734729410.xml","form_type":"4"}},{"id":1323870,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-20T21:16:57.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":370343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares represent an award of restricted stock units which vest as to 1/16th of the shares subject to the award quarterly, beginning February 15, 2025, subject to the Mr. Taylor's continued service through each vesting date."}],"balance_after":844210,"source":{"system":"sec-edgar","filing":"0001601830-24-000249","document":"wk-form4_1734729410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000249/wk-form4_1734729410.xml","form_type":"4"}},{"id":1326226,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-18T23:49:14.000Z","date":"2024-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":7057,"price":6.95,"value":49046.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":473867,"source":{"system":"sec-edgar","filing":"0001601830-24-000247","document":"wk-form4_1734565748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000247/wk-form4_1734565748.xml","form_type":"4"}},{"id":1326225,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-18T23:49:14.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":15668,"price":6.04,"value":94634.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":480924,"source":{"system":"sec-edgar","filing":"0001601830-24-000247","document":"wk-form4_1734565748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000247/wk-form4_1734565748.xml","form_type":"4"}},{"id":3144986,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO"}}],"security":"Employee Stock Option - right to buy","published_at":"2020-05-18T17:41:17.000Z","date":"2018-06-30","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This option was originally granted on March 27, 2017 and was amended on June 30, 2018 to modify the vesting schedule as if the option vested over a three-year period in equal quarterly installments and is disclosed here for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was originally granted on March 27, 2017 and was amended on June 30, 2018 to modify the vesting schedule as if the option vested over a three-year period in equal quarterly installments and is disclosed here for informational purposes only."}],"balance_after":1500000,"derivative":{"exercise_price":2.95,"expiration_date":"2027-03-27","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0000899243-20-013415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924320013415/doc4.xml","form_type":"4"}},{"id":3144985,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO"}}],"security":"Employee Stock Option - right to buy","published_at":"2020-05-18T17:41:17.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a four-year period in equal quarterly installments."}],"balance_after":360000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0000899243-20-013415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924320013415/doc4.xml","form_type":"4"}},{"id":3487304,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO"}}],"security":"Common Stock","published_at":"2019-06-17T13:15:45.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":10000,"price":1.01,"value":10100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $1.05, inclusive. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-19-017151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924319017151/doc4.xml","form_type":"4"}},{"id":3536213,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO"}}],"security":"Employee Stock Option - right to buy","published_at":"2019-05-07T17:05:59.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":469300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a three-year period in equal quarterly installments."}],"balance_after":469300,"derivative":{"exercise_price":1.56,"expiration_date":"2029-05-03","underlying":"Common Stock","underlying_shares":469300},"source":{"system":"sec-edgar","filing":"0000899243-19-012471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924319012471/doc4.xml","form_type":"4"}},{"id":3915046,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO"}}],"security":"Employee Stock Option - right to buy","published_at":"2018-05-29T20:33:44.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is subject to a four-year vesting schedule, vesting 25% on May 24, 2019, and the remaining 75% vesting on a quarterly basis over a three-year period at a rate of 1/12 per quarter."}],"balance_after":400000,"derivative":{"exercise_price":2.9,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-18-014358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924318014358/doc4.xml","form_type":"4"}},{"id":4150652,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO"}}],"security":"Employee Stock Option - right to buy","published_at":"2017-11-27T19:40:34.000Z","date":"2017-11-22","kind":"grant","acquired":true,"shares":129957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant is subject to a six month vesting schedule, vesting 1/6 per month beginning on December 22, 2018."}],"balance_after":129957,"derivative":{"exercise_price":4.1,"expiration_date":"2019-11-22","underlying":"Common Stock","underlying_shares":129957},"source":{"system":"sec-edgar","filing":"0000899243-17-027462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924317027462/doc4.xml","form_type":"4"}},{"id":4150651,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO"}}],"security":"Employee Stock Option - right to buy","published_at":"2017-11-27T19:40:34.000Z","date":"2017-11-22","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25,000 options are exercisable immediately, with the remaining 25,000 exercisable on November 22, 2018."}],"balance_after":50000,"derivative":{"exercise_price":4.1,"expiration_date":"2019-11-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-17-027462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924317027462/doc4.xml","form_type":"4"}}]}